Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk

Carcinogenesis

Volumn 27, Issue 1, 2006, Pages 123-130

  van Herwaarden, Antonius E ^a   Wagenaar, Els ^a   Karnekamp, Barbara ^a   Merino, Gracia ^a   Jonker, Johan W ^a   Schinkel, Alfred H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 3 AMINO 1,4 DIMETHYL 5H PYRIDO[4,3 B]INDOLE; AFLATOXIN B1; BREAST CANCER RESISTANCE PROTEIN; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST FEEDING; BREAST MILK; CARCINOGENESIS; CELL LINE; CELL POLARITY; CONSUMER; CONTROLLED STUDY; DAIRY PRODUCT; DIETARY INTAKE; EXPOSURE; FEMALE; FOOD CONTAMINATION; HEALTH HAZARD; IN VIVO STUDY; LACTATION; LIVER CARCINOGENESIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN TRANSPORT; WILD TYPE;

AFLATOXIN B1; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CARBOLINES; CARBON RADIOISOTOPES; CARCINOGENS; CELLS, CULTURED; DIET; DOGS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; IMIDAZOLES; KIDNEY; MICE; MICE, KNOCKOUT; MILK, HUMAN; NEOPLASM PROTEINS; SWINE; TISSUE DISTRIBUTION;

EID: 29744441900     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi176     Document Type: Article

References (29)

1. Jonker J.W. Smit J.W. Brinkhuis R.F. Maliepaard M. Beijnen J.H. Schellens J.H. and Schinkel A.H. (2000) Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl Cancer Inst. 92 1651-1656.
2. van Herwaarden A.E. Jonker J.W. Wagenaar E. Brinkhuis R.F. Schellens J.H. Beijnen J.H. and Schinkel A.H. (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4 5-b]pyridine (PhIP). Cancer Res. 63 6447-6452.
3. Ushiyama H. Wakabayashi K. Hirose M. Itoh H. Sugimura T. and Nagao M. (1991) Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet but not in patients receiving parenteral alimentation. Carcinogenesis 12 1417-1422.
4. Sugimura T. (2000) Nutrition and dietary carcinogens. Carcinogenesis 21 387-395.
5. Eisenbrand G. and Tang W. (1993) Food-borne heterocyclic amines. Chemistry formation occurrence and biological activities. A literature review. Toxicology 84 1-82.
6. Layton D.W. Bogen K.T. Knize M.G. Hatch F.T. Johnson V.M. and Felton J.S. (1995) Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research. Carcinogenesis 16 39-52.
7. Henry S.H. Bosch F.X. Troxell T.C. and Bolger P.M. (1999) Policy forum: public health. Reducing liver cancer - global control of aflatoxin. Science 286 2453-2454.
8. Bennett J.W. and Klich M. (2003) Mycotoxins. Clin. Microbiol. Rev. 16 497-516.
9. Becker K. Seiwert M. Angerer J. Heger W. Koch H.M. Nagorka R. Rosskamp E. Schluter C. Seifert B. and Ullrich D. (2004) DEHP metabolites in urine of children and DEHP in house dust. Int. J. Hyg. Environ. Health 207 409-417.
10. Dostal L.A. Weaver R.P. and Schwetz B.A. (1987) Transfer of di(2-ethylhexyl) phthalate through rat milk and effects on milk composition and the mammary gland. Toxicol. Appl. Pharmacol. 91 315-325.
11. De Bruin L.S. Martos P.A. and Josephy P.D. (2001) Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4 5-b]pyridine) in the milk of healthy women. Chem. Res. Toxicol. 14 1523-1528.
12. Paulsen J.E. Steffenson I. Andreasssen A. Vikse R. and Alexander J. (1999) Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4 5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20 1277-1282.
13. Cullen J.M. Ruebner B.H. Hsieh L.S. Hyde D.M. and Hsieh D.P. (1978) Carcinogenicity of dietary aflatoxin M1 in male Fischer rats compared to aflatoxin B1. Cancer Res. 47 1913-1917.
14. Zarba A. Wild C.P. Hall A.J. Montesano R. Hudson G.J. and Groopman J.D. (1992) Aflatoxin M1 in human breast milk from The Gambia West Africa quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis 13 891-894.
15. Jonker J.W. Merino G. Musters S. van Herwaarden A.E. Bolscher E. Wagenaar E. Mesman E. Dale T.C. and Schinkel A.H. (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 11 127-129.
16. Allen J.D. van Loevezijn A. Lakhai J.M. van der Valk M. van Tellingen O. Reid G. Schellens J.H. Koomen G.J. and Schinkel A.H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1 417-425.
17. Pavek P. Merino G. Wagenaar E. Bolscher E. Novotna M. Jonker J.W. and Schinkel A.H. (2004) Human breast cancer resistance protein (BCRP/ ABCG2): Interactions with steroid drugs hormones the dietary carcinogen PhIP and transport of cimetidine. J. Pharmacol. Exp. Ther. 312 144-152.
18. Doyle L.A. and Ross D.D. (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 7340-7358.
19. Jonker J.W. Buitelaar M. Wagenaar E. et al. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl Acad. Sci USA 99 15649-15654.
20. Imai Y. Nakane M. Kage K. Tsukahara S. Ishikawa E. Tsuruo T. Miki Y. and Sugimoto Y. (2002) C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1 611-616.
21. Zamber C.P. Lamba J.K. Yasuda K. Farnum J. Thummel K. Schuetz J.D. and Schuetz E.G. (2003) Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13 19-28.
22. Merino G. van Herwaarden A.E. Wagenaar E. Jonker J.W. and Schinkel A.H. (2005) Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 67 1765-1771.
23. Zhou S. Schuetz J.D. Bunting K.D. et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 1028-1034.
24. Asakura A. and Rudnicki M.A. (2002) Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 30 1339-1345.
25. Merino G. Jonker J.W. Wagenaar E. Pulido M.M. Molina A.J. Alvarez A.I. and Schinkel A.H. (2005) Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab. Dispos. 33 614-618.
26. Schinkel A.H. and Jonker J.W. (2003) Mammalian drug effiux transporters of the ATP binding cassette (ABC) family: An overview. Adv. Drug Deliv. Rev. 55 3-29
27. Ito S. and Lee A. (2003) Drug excretion into breast milk - overview. Adv. Drug Deliv. Rev. 55 617-627.
28. Wakabayashi K. Ushiyama H. Takahashi M. Nukaya H. Kim S. Hirose M. Ochiai M. Sugimura T. and Nagao M. (1993) Exposure to heterocyclic amines. Environ. Health Perspect. 99 129-133.
29. Martins M.L. and Martins H.M. (2004) Aflatoxin M1 in yoghurts in Portugal. Int. J. Food Microbiol. 91, 315-317.